Blau Farmaceutica (BSP:BLAU3) Institutional Ownership: 7.28% (As of Sep. 08, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:BLAU3 Blau Farmaceutica SA BSP:BLAU3
84 GF Score
Price R$9.68
GF Value R$10.75
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Blau Farmaceutica Institutional Ownership?

Blau Farmaceutica BSP:BLAU3 +1.89% 84 Institutional Ownership is 7.28% as of Sep. 08, 2026. GuruFocus rates BSP:BLAU3 with a GF Score™ of 84/100 and a GF Value™ of R$10.75 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Blau Farmaceutica's institutional ownership is 7.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Blau Farmaceutica's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Blau Farmaceutica's Float Percentage Of Total Shares Outstanding is 0.00%.

Blau Farmaceutica Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Blau Farmaceutica's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Blau Farmaceutica Institutional Ownership Chart

Blau Farmaceutica Historical Data

The historical data trend for Blau Farmaceutica can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 7.48 6.19 6.00 5.86 5.70 5.55 5.55 7.23 7.29 7.28
BSP:BLAU3
84GF Score
Blau Farmaceutica SA BSP:BLAU3
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Blau Farmaceutica Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 7.28% mean?
Blau Farmaceutica (BSP:BLAU3) has a Institutional Ownership of 7.28% as of Sep. 08, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Blau Farmaceutica and its competitors.
Is Blau Farmaceutica's Institutional Ownership too high?
Blau Farmaceutica's current Institutional Ownership is 7.28%. Overall, Blau Farmaceutica has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Blau Farmaceutica's Institutional Ownership compare to ZTS and UTHR?
Blau Farmaceutica's Institutional Ownership of 7.28% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Blau Farmaceutica and its competitors. Blau Farmaceutica's current Institutional Ownership is 7.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blau Farmaceutica stock overvalued right now?
Based on GuruFocus' analysis, Blau Farmaceutica (BSP:BLAU3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$10.75, compared to a current price of R$9.68 — trading 10% below its estimated fair value. The current Institutional Ownership is 7.28%. Blau Farmaceutica's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Blau Farmaceutica (BSP:BLAU3), the current Institutional Ownership is 7.28% as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Blau Farmaceutica (BSP:BLAU3) Overvalued in 2026?

Based on GuruFocus' analysis, Blau Farmaceutica stock appears to be undervalued. The current stock price of R$9.68 is trading 10% below its estimated GF Value™ of R$10.75. GuruFocus considers Blau Farmaceutica to be Modestly Undervalued.

Key valuation signals for BSP:BLAU3:

  • Institutional Ownership: 7.28%
  • GF Value™: R$10.75 vs. price of R$9.68 (10% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the BSP:BLAU3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Blau Farmaceutica Business Description

Address Rodovia Raposo Tavares, No. 2833, Km 30.5, Barro Branco, Cotia, SP, BRA, 06705-030
Blau Farmaceutica SA is engaged in the manufacturing, development and commercialization of complex private-label drugs for the institutional segment. The Company's business activities cover institutional and retail segments, and are divided into four units: 1) Biologicals are a heterogeneous class of products that can be produced using raw materials from biological materials and biotechnological procedures. 2) Oncology line is made up of oral and injectable drugs intended for treating cancer, which encompasses a number of therapeutic classes. 3) Specialties line is made up of products that are used in the hospital's daily routine, in the specialized treatments for infectious diseases and special treatments. 4) Others consist of prescription and non-prescription over-the-counter drugs.
84GF Score

Get the complete analysis for BSP:BLAU3

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$9.68
Price
R$10.75
GF Value